Genvor, Inc.

04/23/2024

Day 1 of the is underway! Come find our CEO Chad Pawlak at booth 72 to connect and learn more about Genvor’s innovative plant health solutions.

Don't miss out on this opportunity to join the conversation at BAW 2024!

04/22/2024

Genvor is set to unveil its latest research on patented peptides for Aflatoxin resistance in corn at the BioAgTech World Congress. Our collaboration with USDA's Agricultural Research Service hopes to drive solutions for the agricultural challenges of today. Stay tuned for updates from from April 22-26!

For more details, click here: https://ir.genvor.com/press-releases/

$GNVR

04/02/2024

Genvor is thrilled to be a participator in the 5th BioAgTech World Congress, taking place from April 22-26, 2024 in Raleigh, North Carolina!

Our CEO Chad Pawlak will be on-site to share the Genvor story with investors, industry executives and media. For more information or to register for the event, please visit: https://ir.genvor.com/press-releases/

$GNVR

02/27/2024

Join us at the World Agri-Tech Innovation Summit in San Francisco on March 19-20, 2024!

We're excited to present our sustainable plant health solutions leveraging patented peptides. Chad Pawlak, our CEO, will be showcasing our innovations and engaging with industry leaders, investors, and the media.

Don't miss this opportunity to learn how we're revolutionizing the agriculture sector!
For more information, read here: https://ir.genvor.com/press-releases/

$GNVR

02/26/2024

Exciting News! Our CEO, Chad Pawlak, was featured on the latest episode of the Xtalks Food Podcast! Listen in as Chad discusses Genvor's vision for sustainable plant health solutions and our groundbreaking partnership with the USDA on antimicrobial peptides.

Don't miss out on this insightful conversation: https://xtalks.com/interview-with-chad-pawlak-ceo-of-genvor-xtalks-food-podcast-ep-147/

$GNVR

This episode of the Xtalks Food Podcast features an interview with with Chad Pawlak, CEO of Genvor.

02/20/2024

Come Meet Us! Genvor to Attend BioSolutions Conference & Expo in Visalia, California; to Showcase Next-Generation Plant Health Solutions at Leading Industry Event

For conference details, click here: https://lnkd.in/eKnycpXV

$GNVR

02/15/2024

Genvor Provides Fiscal First Quarter 2024 Corporate Update; Q1 Highlighted by New CEO Appointment and OTCQB Venture Market Listing to Drive Commercialization Momentum Ahead of Planned FY25 Uplisting

To read more on the quarter, please click here: https://lnkd.in/gBN9bHiV

$GNVR

01/17/2024

Genvor Appoints Veteran Agribusiness Leader Chad Pawlak, Sr. as Chief Executive Officer; Judith Miller to Transition to Chief Business Officer following her Successful Interim CEO term

To learn more about this exciting development, click here: https://ir.genvor.com/press-releases/

$GNVR

12/18/2023

USDA and Genvor Scientists Publish Research Highlighting Broad-Spectrum Efficacy of Genvor's Antimicrobial Peptides; Paper Serves as Validation by USDA Scientists That Genvor AMPs are Highly Effective Against Harmful Fungi

To learn more about this study, visit the company's site here: https://ir.genvor.com/

$GNVR

12/07/2023

Check out our Chief Scientific Officer Clayton Yates in his interview with Proactive Investors following the listing of Genvor on the OTCQB - Genvor sets its Sights on Commercialization after Completing Listing

Click Here to Watch: https://www.proactiveinvestors.com/companies/news/1035417/genvor-sets-its-sights-on-commercialisation-after-completing-listing-1035417.html

$GNVR

12/05/2023

Genvor Begins Trading on the OTCQB Venture Market; Innovative Developer of Sustainable Plant Health Solutions Enters the Public Markets

To learn more about Genvor, visit the company's site here: https://ir.genvor.com/

$GNVR

11/06/2023

Genvor Engages MZ North America to Lead Strategic Investor Relations and Shareholder Communications Program

To Read More, Visit our Newly Launched Investor Relations Site at the Link Here: https://ir.genvor.com/

$GNVR